Value-based care has steadily gained traction in the United States. At the beginning of the century, only three states had executed value-based care programs. Since 2018, that number has grown to 48 out of 50 states. Clearly, if you provide healthcare services in todayâs market, you need to help patients find ways to reduce the burden of their chronic disease and live healthier lives.
Value-based care can only be effective if patients follow their prescribed care plan including taking their medications as directed. That is why medication adherence plays an essential role in value-based care. Both high prescription drug prices and slower time-to-therapy can create barriers to medication adherence. In this article, we describe how improving medication adherence by breaking down these barriers can drive value-based care.
Elliott Publishes Letter on GlaxoSmithKline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
FTSE 100 Closed Down Despite Outperforming European Indexes
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
FTSE Rises, GlaxoSmithKline Shares Gain After Strategy Update
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.